2025-05-02 22:23:19
Latest Post
Strides strengthens Anti-Inflammatory Portfolio with USFDA Approval for Celecoxib Capsules, 100 mg, 200 mg, and 400 mg
KFin Technologies Introduces New-Gen KYC Solution to Streamline Customer Onboarding
Meson Valves India Ltd receives order worth approx Rs. 12.50 crore
Oriental Rail Infrastructure Ltd receives order worth Rs. 2.46 crore
Punjab Chemicals & Crop Protection Ltd recommends dividend of Rs. 3
Stock Report
The Hindustan Housing Company Q3FY22 PAT at Rs. 40.84 lakhs
Posted On : 2022-02-11 16:39:49( TIMEZONE : IST )
has reported Standalone financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 1.5822 crores during the period ended December 31, 2021 as compared to Rs. 1.8676 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. 0.4084 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. 0.6154 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. 168.77 for the period ended December 31, 2021 as compared to Rs. 254.30 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹ 1.5822 crs | ₹1.8676 crs |  -15.28% |
| Net Profit | ₹0.4084 crs | ₹0.6154 crs | -33.64% |
| EPS | ₹168.77 | ₹254.30 | -33.63% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs. 1.5822 crores during the period ended December 31, 2021 as compared to Rs.1.3889 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.0.4084 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.0.3699 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.168.77 for the period ended December 31, 2021 as compared to Rs.152.87 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹ 1.5822 crs | ₹1.3889 crs |  13.92% |
| Net Profit | ₹0.4084 crs | ₹0.3699 crs | 10.41% |
| EPS | ₹168.77 | ₹152.87 | 10.40% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.4.7250 crores during the 9 Months period ended December 31, 2021 as compared to Rs.3.9160 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.1.2970 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.1.0021 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.535.95 for the 9 Months period ended December 31, 2021 as compared to Rs.414.09 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹4.7250 crs | ₹3.9160 crs | 20.66% |
| Net Profit | ₹1.2970 crs | ₹1.0021 crs | 29.43% |
| EPS | ₹535.95 | ₹414.09 | 29.43% |
